Journal
NEUROBIOLOGY OF AGING
Volume 30, Issue 10, Pages 1545-1551Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2007.12.003
Keywords
APOE; Mortality; Dementia; Ischemic heart diseases; Longevity; Gender differences
Categories
Funding
- Swedish Brain Power Initiative
- Alzheimer Foundation
- Karolinska Institutet's Faculty
- Gun & Bertil Stohne's Foundation
Ask authors/readers for more resources
Allele-frequency comparisons between younger and older populations suggest an effect of apolipoprotein E gene (APOE) on mortality, not consistently confirmed by longitudinal data. Our aim was to assess the effect of APOE on survival taking into account the possible contribution of Alzheimer's disease, other dementias, ischemic heart- and cerebrovascular disease (IHCD). In a community-based longitudinal study, the Kungsholmen Project, 75+ year-old individuals (n = 1094) were examined, and followed for 18 years. An increased mortality-risk of 22% in those with the epsilon 4 allele was detected; whereas a 28% decreased mortality-risk was detected in those with the epsilon 2 allele compared to those with the epsilon 3 epsilon 3 genotype. IHCD adjustment did not change the mortality-risk in those with the epsilon 4 allele or the epsilon 2 allele. Dementia accounted for the majority of the increased mortality-risk associated with the epsilon 4 allele, but the protective effect of the epsilon 2 allele remained. Both effects of the epsilon 4 allele and the epsilon 2 allele were strongly modified by gender. A 49% elevated risk for death in men was related to the epsilon 4 allele, and a 36% decreased mortality-risk was found in women with the epsilon 2 allele. These findings suggest different roles for the APOE alleles in survival by gender in old age. (C) 2007 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available